Transmissible Spongiform Encephalopathies (TSE): Understanding Prion Diseases and Their Microbiological Significanc

By -

Transmissible Spongiform Encephalopathies (TSEs) are a rare but highly fatal group of neurodegenerative diseases that affect both humans and animals. Unlike conventional infectious diseases caused by bacteria, viruses, or fungi, TSEs are caused by prions—abnormally folded proteins that can induce misfolding of normal cellular proteins in the brain, leading to severe brain damage and characteristic sponge-like changes (spongiform degeneration).

What are Transmissible Spongiform Encephalopathies (TSEs)?

TSEs are progressive, fatal, and transmissible neurodegenerative disorders. They are unique because they do not contain any nucleic acid (DNA or RNA). Instead, the infectious agent is a misfolded form of a normal host protein called Prion Protein (PrP).

Common Types of TSEs

  • In Humans: Creutzfeldt-Jakob Disease (CJD), Variant CJD (vCJD), Gerstmann-Sträussler-Scheinker syndrome (GSS), Fatal Familial Insomnia (FFI), and Kuru.
  • In Animals: Bovine Spongiform Encephalopathy (BSE or “Mad Cow Disease”), Scrapie (sheep and goats), Chronic Wasting Disease (deer and elk), and Transmissible Mink Encephalopathy.

The Causative Agent – Prions

Prions are proteinaceous infectious particles that are resistant to heat, radiation, and disinfectants. The normal prion protein (PrPC) is found on the surface of neurons, but when it misfolds into the abnormal form (PrPSc), it becomes resistant to protease enzymes and triggers a chain reaction of misfolding in other normal proteins. This leads to accumulation of protein aggregates in brain tissue, causing neuronal death and spongiform changes.

Pathogenesis of TSEs

  1. Exposure to abnormal prion protein (through infected tissue or genetic mutation).
  2. Conversion of normal cellular prion protein (PrPC) into the pathogenic isoform (PrPSc).
  3. Accumulation of PrPSc aggregates within the central nervous system.
  4. Progressive neuronal loss, gliosis, and development of spongiform vacuolation in brain tissue.

Clinical Features

The symptoms of TSEs vary depending on the disease type but generally include:

  • Rapidly progressive dementia
  • Loss of coordination and balance (ataxia)
  • Visual disturbances
  • Personality changes and psychiatric symptoms
  • Myoclonus (sudden muscle jerks)
  • Coma and death (usually within months to a few years)

Transmission and Risk Factors

TSEs can be transmitted through several mechanisms:

  • Consumption of infected animal products (as in variant CJD from BSE).
  • Use of contaminated surgical instruments or medical devices.
  • Transplantation of infected tissue (e.g., corneal or dura mater grafts).
  • Inherited mutations in the PRNP gene (familial forms).

Diagnosis of TSEs

Diagnosis is challenging because symptoms overlap with other neurological disorders. Diagnostic methods include:

  • Electroencephalography (EEG): Shows periodic sharp wave complexes in CJD.
  • Magnetic Resonance Imaging (MRI): Reveals hyperintensity in basal ganglia or thalamus.
  • Cerebrospinal Fluid (CSF) Tests: Detection of 14-3-3 protein or RT-QuIC assay.
  • Brain Biopsy or Autopsy: Confirms diagnosis through histopathological examination showing spongiform changes and PrP deposition.

Control and Prevention

  • Strict control over animal feed and slaughter practices (especially avoiding feeding ruminant-derived proteins).
  • Decontamination of surgical instruments using strong alkali or autoclaving at higher temperatures (134°C for 18 minutes).
  • Screening of blood donors and avoidance of high-risk materials.
  • Public health surveillance of CJD and BSE cases.

Conclusion

Transmissible Spongiform Encephalopathies (TSEs) represent a unique class of infectious diseases caused by protein misfolding rather than traditional microorganisms. They challenge our understanding of infection, immunity, and disease transmission. Ongoing research on prion biology offers new insights into neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease, highlighting the importance of prion research in modern microbiology and neuroscience.

References

  • World Health Organization (WHO) – Guidelines on Transmissible Spongiform Encephalopathies.
  • Centers for Disease Control and Prevention (CDC) – Prion Diseases Overview.
  • Prusiner SB, Nobel Lecture, 1997 – “Prions: Novel Infectious Pathogens Causing Scrapie and Creutzfeldt-Jakob Disease.”

💬 About the Author

Siva Sankar is a Pharmaceutical Microbiology Consultant and Auditor with extensive experience in sterility testing, validation, and GMP compliance. He provides consultancy, training, and documentation services for pharmaceutical microbiology and cleanroom practices.

📧 Contact: siva17092@gmail.com
Mobile: 09505626106

📱 Disclaimer: This article is for educational purposes and does not replace your laboratory’s SOPs or regulatory guidance. Always follow validated methods and manufacturer instructions.

Popular posts from this blog

Non-Viable particle count (NVPC)

By -
Image
Particle mater in room air limits are in particles of 0.5 μm and larger per cubic meter. ISO = cubic meter (m 3 ) FD Standard 209 E = cubic feet (ft 3 )   ISO class equal to federal standard 209 E class .  1m 3  = 35.31 ft 3 1m = 100 cm Adapted from former Federal Standard No. 209 E,                ISO = international organization for standard 14644 part -1, may -1999 p ublished. Maximum concentration limits (particles M3 of air) for particles equal to and larger than the considered sizes shown below: (a) ISO Classification Number(N) 0.1µm 0.2µm 0.3µm 0.5µm 1.0µm 5.0µm ISO 1 b                    10 d                 2 d d d e ISO 2 10...
Read more

Alert and Action Limits

By -
In pharmaceuticals alert and action limits are very important, because these limits are effective control to the process. alert and action limits are in house limits, these limits must be less than guideline limits or define limits. Alert and action limits defined based on trend analysis. alert and action limits are like a barrier before the guideline limits. Alert Limit: To be alert the microbial counts reach to this alert level. It is nor necessary to take any action. Possible deviation from normal process condition This is a trigger, that something is going wrong means microbial count increasing that area. Action Limits: When microbial count reach this action limits then action is mandatory. To control the  microbial count in the area. Signal an apparent deviation from normal process condition And require immediate action. If not controlled, we might get area failure. These alert and action limits must be less than final limits. Example : A...
Read more

TNTC vs TFTC

By -
Image
Too Numerous To Count (TNTC) or Too Many To Counts (TMTC) In samples with very high bacterial concentration, that is not suitable for counting (unable to get accurate counts) and reports the results as "to numerous to count" (TNTC). While the best solution is to collect another sample and dilute to get a more accurate counts, this might not always to be possible. Ideally one plate with 200 to 250 colonies are used. Counts above 250 are considered "to numerous to count" (TNTC), because it is impossible to count the colonies. plates countable range 25 to 250. Too Few To Count (TFTC): If there are less than 30 colonies on the plate, small errors in dilution technique or the presence of a few contaminants will have a drastic effect on the final count this count is called too few to count (TFTC).
Read more